Handelsbanken Fonder AB - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$160,000
-37.5%
28,0000.0%0.00%0.0%
Q4 2021$256,000
-14.4%
28,0000.0%0.00%
-50.0%
Q3 2021$299,000
-31.3%
28,0000.0%0.00%0.0%
Q2 2021$435,000
+23.6%
28,000
+29.0%
0.00%0.0%
Q1 2021$352,000
+28.0%
21,700
+66.9%
0.00%0.0%
Q4 2020$275,000
+42.5%
13,0000.0%0.00%
+100.0%
Q3 2020$193,000
-49.5%
13,000
-50.0%
0.00%
-50.0%
Q2 2020$382,00026,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders